CD79A and graft versus host disease: The results showed that those target genes were significantly enriched in viral myocarditis, CAMs, allograft rejection, graft-versus-host disease, type I diabetes mellitus, antigen processing, presentation and autoimmune thyroid disease, asthma, tuberculosis, leishmaniasis, human T-cell leukemia virus infection, and the intestinal immune network for IgA production.